Sanofi

Annual General Shareholders' Meeting of May 2, 2018 - Seite 2

The voting results will be available on the Company's website (www.sanofi.com/AGM2018) in the coming days.

The audiocast of the Annual General Shareholder Meeting is available on the Company's website (www.sanofi.com/AGM2018).

During the Board of Directors session following the meeting, the Board decided to review the composition of its Committees as follows:

    Audit Committee Strategic Committee Compensation Committee Chairwoman/
Chairman Fabienne Lecorvaisier* Serge Weinberg* Patrick Kron* Members Emmanuel Babeau*
Christian Mulliez
Diane Souza* Laurent Attal
Olivier Brandicourt
Patrick Kron* Claudie Haigneré*
Christian Mulliez
Diane Souza*     Appointments & Governance Committee Scientific Committee Chairman Serge Weinberg* Thomas Südhof* Members Claudie Haigneré*
Patrick Kron* Laurent Attal
Melanie Lee*
Serge Weinberg* (* Independent Director)
(** Director representing employees)

 
About Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life
 
Media Relations Contact
Jack Cox
Tel.: [phone]
[e-mail]
Investor Relations Contact
George Grofik
Tel.: [phone]
[e-mail]

Press release (PDF)

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via Globenewswire